Published in Mol Gen Genet on December 01, 1986
In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family. Proc Natl Acad Sci U S A (1998) 5.04
The region of the IncN plasmid R46 coding for resistance to beta-lactam antibiotics, streptomycin/spectinomycin and sulphonamides is closely related to antibiotic resistance segments found in IncW plasmids and in Tn21-like transposons. Nucleic Acids Res (1987) 3.54
Transposon Tn5090 of plasmid R751, which carries an integron, is related to Tn7, Mu, and the retroelements. J Bacteriol (1994) 2.97
Sequence requirements of Escherichia coli attTn7, a specific site of transposon Tn7 insertion. J Bacteriol (1988) 1.85
The Tn7 transposase is a heteromeric complex in which DNA breakage and joining activities are distributed between different gene products. EMBO J (1996) 1.74
Structural and functional characterization of tnpI, a recombinase locus in Tn21 and related beta-lactamase transposons. J Bacteriol (1990) 1.60
Characterizing the flagellar filament and the role of motility in bacterial prey-penetration by Bdellovibrio bacteriovorus. Mol Microbiol (2006) 1.60
Identification of a transposon Tn7-dependent DNA-binding activity that recognizes the ends of Tn7. Proc Natl Acad Sci U S A (1987) 1.57
DNA sequence analysis of five genes; tnsA, B, C, D and E, required for Tn7 transposition. Nucleic Acids Res (1990) 1.54
Tn7 transposition: recognition of the attTn7 target sequence. Proc Natl Acad Sci U S A (1989) 1.52
Predation by Bdellovibrio bacteriovorus HD100 requires type IV pili. J Bacteriol (2007) 1.51
Interaction of the Tn7-encoded transposition protein TnsB with the ends of the transposon. Nucleic Acids Res (1991) 1.45
Avoiding self: two Tn7-encoded proteins mediate target immunity in Tn7 transposition. EMBO J (1997) 1.39
Bacterial transposon Tn7 utilizes two different classes of target sites. J Bacteriol (1990) 1.36
Tn7 recognizes transposition target structures associated with DNA replication using the DNA-binding protein TnsE. Genes Dev (2001) 1.33
Synapsis and DNA cleavage in phiC31 integrase-mediated site-specific recombination. Nucleic Acids Res (2004) 1.30
Tn7 transposition as a probe of cis interactions between widely separated (190 kilobases apart) DNA sites in the Escherichia coli chromosome. J Bacteriol (1996) 1.30
Purification and characterization of TnsC, a Tn7 transposition protein that binds ATP and DNA. Nucleic Acids Res (1992) 1.24
Host proteins can stimulate Tn7 transposition: a novel role for the ribosomal protein L29 and the acyl carrier protein. EMBO J (1998) 1.22
Manipulating each MreB of Bdellovibrio bacteriovorus gives diverse morphological and predatory phenotypes. J Bacteriol (2009) 1.17
Recognition of Escherichia coli attTn7 by transposon Tn7: lack of specific sequence requirements at the point of Tn7 insertion. J Bacteriol (1988) 1.15
Molecular characterization of the class II multiresistance transposable element Tn1403 from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1991) 1.14
Transposon Tn554 encodes three products required for transposition. EMBO J (1988) 1.09
Analysis of genetic localization of the type I trimethoprim resistance gene from Escherichia coli isolated in Finland. Antimicrob Agents Chemother (1991) 1.06
Tn7 transposition creates a hotspot for homologous recombination at the transposon donor site. Genetics (1993) 1.06
Recognition of triple-helical DNA structures by transposon Tn7. Proc Natl Acad Sci U S A (2000) 1.04
Three motAB stator gene products in Bdellovibrio bacteriovorus contribute to motility of a single flagellum during predatory and prey-independent growth. J Bacteriol (2010) 0.98
Isolation and characterization of Tn7 transposase gain-of-function mutants: a model for transposase activation. EMBO J (2000) 0.95
Purification and characterisation of the TnsB protein of Tn7: a transposition protein that binds to the ends of Tn7. Nucleic Acids Res (1991) 0.93
Activity of Bdellovibrio hit locus proteins, Bd0108 and Bd0109, links Type IVa pilus extrusion/retraction status to prey-independent growth signalling. PLoS One (2013) 0.89
Tn552 transposase purification and in vitro activities. EMBO J (1995) 0.86
DNA damage differentially activates regional chromosomal loci for Tn7 transposition in Escherichia coli. Genetics (2008) 0.85
Co-spread of metal and antibiotic resistance within ST3-IncHI2 plasmids from E. coli isolates of food-producing animals. Sci Rep (2016) 0.83
Nucleases in Bdellovibrio bacteriovorus contribute towards efficient self-biofilm formation and eradication of preformed prey biofilms. FEMS Microbiol Lett (2013) 0.81
Mutagenesis of RpoE-like sigma factor genes in Bdellovibrio reveals differential control of groEL and two groES genes. BMC Microbiol (2012) 0.79
A coiled-coil-repeat protein 'Ccrp' in Bdellovibrio bacteriovorus prevents cellular indentation, but is not essential for vibroid cell morphology. FEMS Microbiol Lett (2010) 0.77
Trans-complementable copy-number mutants of plasmid ColE1. Nature (1980) 17.11
Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA (2000) 10.17
The transposon Tn1 as a probe for studying ColE1 structure and function. Mol Gen Genet (1977) 8.71
Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med (1989) 4.72
The successful implementation of pharmaceutical practice guidelines. Analysis of associated outcomes and cost savings. SWiPE Group. Systematic Withdrawal of Perioperative Expenses. Anesthesiology (1997) 3.92
Trends in perinatal transmission of HIV/AIDS in the United States. JAMA (1999) 3.86
Identification of xanthurenic acid as the putative inducer of malaria development in the mosquito. Nature (1998) 3.56
HeartCare: an Internet-based information and support system for patient home recovery after coronary artery bypass graft (CABG) surgery. J Adv Nurs (2001) 3.36
Dissection of the transposition process: a transposon-encoded site-specific recombination system. Mol Gen Genet (1979) 3.32
Marriage, monogamy and HIV: a profile of HIV-infected women in south India. Int J STD AIDS (2000) 2.59
Complementation of transfer deficient ColE1 mutants. Mol Gen Genet (1977) 2.47
Escherichia coli XerC recombinase is required for chromosomal segregation at cell division. New Biol (1991) 2.44
Communication between GPs and cooperatives is poor for terminally ill patients. BMJ (1997) 2.41
Plasmid ColE1 conjugal mobility: the nature of bom, a region required in cis for transfer. Mol Gen Genet (1982) 2.33
Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients. Am J Med Genet (2001) 2.19
Polypeptides expressed in Escherichia coli K-12 minicells by transposition elements Tn1 and Tn3. J Bacteriol (1979) 2.17
Interferon therapy for condylomata acuminata. N Engl J Med (1986) 2.16
Next-generation sequencing: the solution for high-resolution, unambiguous human leukocyte antigen typing. Hum Immunol (2010) 1.95
Patent threat to research. Nature (1997) 1.93
Selective neuronal targeting in prion disease. Neuron (1997) 1.82
Screening for Duchenne muscular dystrophy. Arch Dis Child (1989) 1.78
Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med (2000) 1.76
Anogenital warts in childhood. Child Abuse Negl (1989) 1.75
Squalamine: an aminosterol antibiotic from the shark. Proc Natl Acad Sci U S A (1993) 1.67
Study of restriction fragment length polymorphism analysis and spoligotyping for epidemiological investigation of Mycobacterium bovis infection. J Clin Microbiol (1999) 1.64
Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting. JAMA (1996) 1.64
Transposon-specified, site-specific recombination systems. Cold Spring Harb Symp Quant Biol (1981) 1.62
Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation. Proc Natl Acad Sci U S A (1990) 1.59
Germline mutation of the tumour suppressor PTEN in Proteus syndrome. J Med Genet (2002) 1.50
Primary immunisations in Liverpool. II: Is there a gap between consent and completion? Arch Dis Child (1993) 1.49
Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activity. Clin Infect Dis (2000) 1.48
Quantitative measurement of calcium flux through muscle and neuronal nicotinic acetylcholine receptors. J Neurosci (1994) 1.45
Uncertainty and opposition of medical students toward assisted death practices. J Pain Symptom Manage (2001) 1.43
Fixed drug eruptions in children. J Pediatr (1999) 1.40
Double stapled transabdominal anastomosis for one-stage resection of acute sigmoid volvulus. Br J Surg (1997) 1.40
Primary immunisations in Liverpool. I: Who withholds consent? Arch Dis Child (1993) 1.40
A new polymorphic probe which defines the region of chromosome 19 containing the myotonic dystrophy locus. Am J Hum Genet (1990) 1.39
Preventing perinatal HIV infection. How far have we come? JAMA (1996) 1.39
Effects of methyl beta-cyclodextrin on EDHF responses in pig and rat arteries; association between SK(Ca) channels and caveolin-rich domains. Br J Pharmacol (2007) 1.39
A coordinated programme will identify needs. Practice nurses' role in screening elderly people. Prof Nurse (1991) 1.39
Euphemisms in nursing's future. 1975. Image J Nurs Sch (1997) 1.37
Circles: the replication-recombination-chromosome segregation connection. Proc Natl Acad Sci U S A (2001) 1.34
Early detection of PrPres in BSE-infected bovine PrP transgenic mice. Arch Virol (2003) 1.34
ESGE-ESGENA Guideline: cleaning and disinfection in gastrointestinal endoscopy. Endoscopy (2008) 1.30
Transposon-specified site-specific recombination. Proc Natl Acad Sci U S A (1982) 1.28
Multimer resolution systems of ColE1 and ColK: localisation of the crossover site. Mol Gen Genet (1985) 1.27
Release of the cellular prion protein from cultured cells after loss of its glycoinositol phospholipid anchor. Glycobiology (1993) 1.26
Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1. J Biol Chem (1996) 1.25
Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Int J Mol Med (2003) 1.21
Unusual electrocardiographic presentation of right ventricular myocardial infarction. Tex Heart Inst J (1996) 1.21
A three-year study of impetigo in Sydney. Med J Aust (1987) 1.20
D4F104S1 deletion in facioscapulohumeral muscular dystrophy: phenotype, size, and detection. Neurology (2003) 1.20
Presentation of cutaneous mastocytosis in 173 children. Australas J Dermatol (2001) 1.17
Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group. N Engl J Med (1995) 1.17
Recombination events that locate myotonic dystrophy distal to APOC2 on 19q. Genomics (1989) 1.15
Transposition and transposition immunity of transposon Tn3 derivatives having different ends. EMBO J (1984) 1.13
A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med (1991) 1.13
Vulvar disease in children: a clinical audit of 130 cases. Pediatr Dermatol (2000) 1.12
99th ENMC international workshop: myotonic dystrophy: present management, future therapy. 9-11 November 2001, Naarden, The Netherlands. Neuromuscul Disord (2002) 1.12
Follow-up evaluation of a phase II prostate cancer vaccine trial. Prostate (1999) 1.11
Effects of Holliday junction position on Xer-mediated recombination in vitro. EMBO J (1995) 1.10
Patient tolerance of craniotomy performed with the patient under local anesthesia and monitored conscious sedation. Neurosurgery (1998) 1.10
Use of ultrasonography in the diagnosis of childhood pilomatrixoma. Pediatr Dermatol (2000) 1.10
Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides. Prostate (1998) 1.09
Control of influenza A on a bone marrow transplant unit. Infect Control Hosp Epidemiol (2000) 1.08
Use of drug effect interaction modeling with Monte Carlo simulation to examine the impact of dosing interval on the projected antiviral activity of the combination of abacavir and amprenavir. Antimicrob Agents Chemother (2000) 1.07
Provider-initiated HIV testing and counseling in TB clinical settings: tools for program implementation. Int J Tuberc Lung Dis (2008) 1.05
Phase II prostate cancer vaccine trial: report of a study involving 37 patients with disease recurrence following primary treatment. Prostate (1999) 1.05
Clostridium perfringens beta-toxin forms potential-dependent, cation-selective channels in lipid bilayers. Infect Immun (2000) 1.05
Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol (2001) 1.05
The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum (1984) 1.04
Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV. Perinatal AIDS Collaborative Transmission Studies. AIDS (1998) 1.04
Treatment of macrophages with oxidized low-density lipoprotein increases their intracellular glutathione content. Biochem J (1991) 1.04
Pregnancy Risk Assessment Monitoring System (PRAMS): unintended pregnancy among women having a live birth. PRAMS Working Group. J Womens Health Gend Based Med (1999) 1.02
ColE plasmid replication in DNA polymerase I-deficient strains of Escherichia coli. Mol Gen Genet (1976) 1.02
The effect of asymptomatic infection with HTLV-III on the response of anogenital warts to intralesional treatment with recombinant alpha 2 interferon. J Infect Dis (1986) 1.02
Atovaquone for salvage treatment and suppression of toxoplasmic encephalitis in patients with AIDS. Atovaquone/Toxoplasmic Encephalitis Study Group. Clin Infect Dis (1997) 1.01
Comparison of tetracycline and minocyclie transport in Escherichia Coli. Antimicrob Agents Chemother (1975) 1.01
The sss gene product, which affects pyoverdin production in Pseudomonas aeruginosa 7NSK2, is a site-specific recombinase. Mol Microbiol (1994) 1.01
Genetics of inflammatory bowel disease: scientific and clinical implications. Best Pract Res Clin Gastroenterol (2003) 1.01
Transposon Tn1 intra-molecular transposition. Mol Gen Genet (1984) 1.00
Disseminated invasive infection due to Metarrhizium anisopliae in an immunocompromised child. J Clin Microbiol (1998) 0.99
Apolipoprotein B synthesis by human liver and intestine in vitro. Proc Natl Acad Sci U S A (1986) 0.98
Incompatibility and transforming efficiency of ColE1 and related plasmids. Mol Gen Genet (1978) 0.97
Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function. J Cell Physiol (2007) 0.97
Multiple lifestyle and psychosocial risks and delivery of small for gestational age infants. Obstet Gynecol (2001) 0.97
Treatment of childhood vulvar lichen sclerosus with potent topical corticosteroid. Pediatr Dermatol (1997) 0.97
Donor scoring system for cadaveric renal transplantation. Am J Transplant (2001) 0.96
Multiple lentigines confined to a resolving psoriatic plaque, treated without phototherapy. Clin Exp Dermatol (1995) 0.96
Additional evidence for lack of transmission of HIV infection by close interpersonal (casual) contact. AIDS (1990) 0.95
A positron emission tomography study of binaurally and dichotically presented stimuli: effects of level of language and directed attention. Brain Lang (1996) 0.94
Dermatological presentations of infantile myofibromatosis: a review of 27 cases. Australas J Dermatol (2000) 0.94
Pregnancy outcome after successful external cephalic version for breech presentation at term. Am J Obstet Gynecol (1997) 0.94
Attempted transfer of antibiotic resistance between Bacteroides and Escherichia coli. J Gen Microbiol (1976) 0.94
Identification of a novel DNA probe for strain typing Mycobacterium bovis by restriction fragment length polymorphism analysis. J Clin Microbiol (2000) 0.93
Source of unique tumour antigens. Nature (1994) 0.93